Metalloproteinases and their inhibitors—diagnostic and therapeutic opportunities in orthopedics

B Pasternak, P Aspenberg - Acta orthopaedica, 2009 - Taylor & Francis
Matrix metalloproteinases (MMPs) and related enzymes (ADAMs, ADAMTS) and their
inhibitors control matrix turnover and function. Recent advances in our understanding of …

Metalloproteases and inhibitors in arthritic diseases

J Martel-Pelletier, DJ Welsch, JP Pelletier - Best practice & research …, 2001 - Elsevier
Controlling degradation of the extracellular matrix is crucial in arthritic diseases such as
osteoarthritis (OA) and rheumatoid arthritis (RA), as conventional treatments do not …

Metalloproteinases: their role in arthritis and potential as therapeutic targets

IM Clark, AE Parker - Expert opinion on therapeutic targets, 2003 - Taylor & Francis
Irreversible degradation of articular cartilage is a major feature of the arthritides, and its
prevention is a therapeutic goal which has been difficult to achieve. Enzymes from the matrix …

Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases

T Cawston - Molecular medicine today, 1998 - cell.com
The matrix metalloproteinases (MMPs) are a unique family of metalloenzymes, which, once
activated, can destroy all the components of cartilage. MMPs are found in resorbing …

[HTML][HTML] ADAMTS and ADAM metalloproteinases in osteoarthritis–looking beyond the 'usual suspects'

CY Yang, A Chanalaris, L Troeberg - Osteoarthritis and cartilage, 2017 - Elsevier
Summary Introduction Matrix metalloproteinases (MMPs) and 'aggrecanase'a disintegrin
and metalloproteinase with thrombospondin motifs (ADAMTSs) are well established to play …

Molecular targets in osteoarthritis: metalloproteinases and their inhibitors

PS Burrage, CE Brinckerhoff - Current drug targets, 2007 - ingentaconnect.com
The debilitating destruction of joint tissues seen in osteoarthritis (OA) is due, in large part, to
the degradative activity of metalloproteinase (MP) enzymes that target extracellular matrix …

Matrix metalloproteinases and their clinical applications in orthopaedics

DS Bramono, JC Richmond, PP Weitzel… - Clinical Orthopaedics …, 2004 - journals.lww.com
Imbalance in the expression of matrix metalloproteinases and their inhibitors contribute
considerably to abnormal connective tissue degradation prevalent in various orthopaedic …

Inhibition of MMPs and ADAM/ADAMTS

CJ Malemud - Biochemical pharmacology, 2019 - Elsevier
Abstract Matrix metalloproteinases (MMPs), A Disintegrin and Metalloproteinase (ADAM)
and A Disintegrin and Metalloproteinase with Thrombospondin Motif (ADAMTS) are zinc …

What are the roles of metalloproteinases in cartilage and bone damage?

G Murphy, MH Lee - Annals of the rheumatic diseases, 2005 - ard.bmj.com
A role for metalloproteinases in the pathological destruction in diseases such as rheumatoid
arthritis and osteoarthritis, and the irreversible nature of the ensuing cartilage and bone …

[HTML][HTML] Metalloproteinases and their inhibitors: potential for the development of new therapeutics

M Raeeszadeh-Sarmazdeh, LD Do, BG Hritz - Cells, 2020 - mdpi.com
The metalloproteinase (MP) family of zinc-dependent proteases, including matrix
metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs), and a disintegrin …